CION Cancer Clinics
First-line, second-line and third-line treatment for colon cancer | CION Cancer Clinics
A line of treatment is one combination of medicines, given while it keeps colon cancer that has spread under control. First-line is where you start. When scans show the cancer growing again, the team switches to second-line, then third-line. This page explains what each line usually involves, how the switch is decided, and why the question of liver surgery is asked again at every scan. At CION Cancer Clinics, a multidisciplinary team plans colon cancer treatment for your stage, from surgery to chemotherapy and follow-up.
On this page
- What do first-line, second-line and third-line treatment mean?
- What does each line usually involve?
- How does the team decide it is time for the next line?
- What do the words in a scan report and plan mean?
- Which beliefs about lines of treatment are wrong?
- What this page cannot tell you
- Common questions about lines of treatment
The short answer
What do first-line, second-line and third-line treatment mean?
A line of treatment is one combination of medicines, given for as long as it keeps the cancer under control and you can cope with it. First-line is the combination you start with. When scans show the cancer growing again, the team switches to a different combination. That is second-line. The next switch is third-line.
Where the word applies
You will hear it when colon cancer has spread and cannot be removed by surgery today. The aim is to hold the cancer back for as long as possible while you live as normally as you can. Each line is chosen from the markers tested on your tumour, the medicines you have already had and how strong you feel.
The question that is never closed
Lines are not a countdown. Some people whose liver spots shrink well on first-line treatment become suitable for surgery, and spread limited to the liver that can be removed is potentially curable for some of them. So the tumour board keeps asking whether surgery has become possible at every scan. The page on conversion chemotherapy explains how that happens.
Moving to a new line means the plan changed. It does not mean the team has given up.Line by line
What does each line usually involve?
The exact medicines depend on your tumour's markers. This is the usual shape of the journey, not a fixed menu.
First-line
Usually a chemotherapy pair such as FOLFOX, CAPOX or FOLFIRI, often with a targeted drug. Which targeted drug depends on the RAS result and the side of the colon the tumour began in. The details sit on the choosing a regimen page.
Different if
- The tumour is MSI-high, when immunotherapy often comes first
- You are frail, when one gentler medicine may be used
Maintenance
When the cancer is controlled after several months, the strongest drugs are often dropped and a lighter medicine continues. Some people take a planned break. This is still first-line, just quieter.
Second-line
The chemotherapy partner is usually swapped. If oxaliplatin was used first, irinotecan usually comes next, or the other way round. A targeted drug is often kept or changed.
Markers that open doors here
- A BRAF change, which has its own targeted pairing
- HER2, a rarer target with its own medicines
Third-line and later
Tablet medicines such as trifluridine-tipiracil or regorafenib, a return to a drug that worked before, or a clinical trial. For some people, the right choice here is to focus on comfort instead.
Not everyone needs or reaches a later line. Both are normal.Not sure whether this applies to you?
Ask an oncologistMaking the switch
How does the team decide it is time for the next line?
Scans are repeated on a schedule
A CT scan is usually repeated every two or three months. The CEA blood test, a marker some colon cancers release, may be checked between scans. One rising number on its own does not force a switch.
The scans are compared, not read alone
The radiologist measures the same spots each time. Shrinking or steady spots mean the line is working. Clear growth, or new spots, usually means it has stopped working.
Side effects are weighed as well
A line can also end because you cannot cope with it, even while it still controls the cancer. Often the dose or a single drug is changed first, so the line can carry on.
The tumour board reviews the next step
Oncologists and surgeons look at the scans together. They check whether surgery or ablation has become possible before choosing the next combination.
You are part of the decision
Your oncologist explains what the next line offers and what it costs you in side effects and hospital visits. Saying you want a break or a gentler plan is allowed.
On your report
What do the words in a scan report and plan mean?
- Response
- The spots have shrunk since the last scan. The line is working.
- Stable disease
- The spots have stayed about the same size. This also counts as the treatment working.
- Progression
- The spots have grown or new ones have appeared. This is usually the signal to discuss the next line.
- Maintenance
- A lighter medicine given after the strongest phase, to hold the control already gained.
- Rechallenge
- Going back to a drug that worked earlier, after a gap. See rechallenge for when it is tried.
- Wild-type
- No change was found in that gene. A RAS wild-type tumour may respond to cetuximab or panitumumab.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Which beliefs about lines of treatment are wrong?
Switching is the expected next step when cancer learns to grow on one combination. Many people spend a long, active stretch of life on second-line treatment. The team is planning ahead, not stepping back.
The first line is usually the one most likely to shrink the cancer, so it is chosen with the most care. Holding back the right medicine rarely helps. It can also close the window for liver surgery.
Each line works differently. A cancer that has learned to resist one drug can still respond to a different one, which is why lines exist at all.
A planned break is watched with regular scans, and treatment restarts if the cancer grows. For some people it brings real relief from side effects without harming control.
Being straight with you
What this page cannot tell you
It cannot tell you which line suits you next, or how long any line will work for you. That depends on your markers, the medicines you have already had, your liver and kidney function and how you are coping. Only an oncologist who has seen your scans and reports can answer it.
Who this does not apply to
If the cancer has not spread beyond the colon and nearby lymph nodes, chemotherapy after surgery is a single planned course, not a line. If the cancer began in the rectum, radiation often enters the plan, so see the rectal cancer pages. If spread is limited and removable, start with the treatment sequence instead.
Where CION fits
At CION, medical oncologists give chemotherapy, targeted therapy and immunotherapy, and the tumour board reviews your scans at each switch. Scans and any surgery are arranged at accredited partner hospitals. Palliative care for symptoms can run alongside every line.
Bring a list of every drug you have had, with the dates. It shapes the choice of the next line.Questions we are asked
Common questions about lines of treatment
How long does first-line treatment last?
There is no fixed length. A line continues for as long as scans show control and you can cope with it. The strongest phase is often eased into a lighter maintenance phase after several months. Your oncologist reviews this at every scan.
Can liver surgery still happen after second-line treatment?
Sometimes. If the liver spots shrink enough on any line, the tumour board can reconsider surgery or ablation, and removable liver spread is potentially curable for some people. It is less common after later lines, so ask whether a liver surgeon has seen your latest scans.
Why does my tumour's RAS or BRAF result matter so much?
These markers decide which targeted drugs can help. Cetuximab and panitumumab only work when RAS is normal. A BRAF change has its own combination. See why RAS and BRAF are tested first for the details.
Does immunotherapy fit into these lines?
For MSI-high or MMR-deficient tumours, yes, and it is often the first line. For most other colon cancers it does not work on its own, so it is not routinely offered. Your marker report will say which group your tumour is in.
Is a third-line medicine worth taking?
For some people it holds the cancer back and they feel well on it. For others the side effects outweigh the gain. Ask your oncologist what it is likely to offer you in particular, and weigh it against what matters to you.
What happens when no standard line is left?
A clinical trial may be possible, or a return to a drug that worked before. Choosing comfort-focused care is also a real choice. Palliative care keeps managing pain, appetite and tiredness whichever path you take.
Can I take a break between lines?
Often, yes, when the cancer is under control. A planned break is watched with regular scans and blood tests, and treatment restarts if the cancer grows. Ask before stopping on your own, because an unplanned gap is not watched in the same way.
Should I get a second opinion before changing lines?
It is reasonable at any switch, especially if nobody has said whether surgery was reconsidered. Bring your scans on CD, the marker report and a list of past drugs. The CION helpline can arrange a review of your plan.
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Colorectal Cancer Chemotherapy
- American Cancer Society — Colorectal Cancer Targeted Therapy
- National Cancer Institute — Colon Cancer Treatment
- ESMO — Colorectal Cancer: A Guide for Patients
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Has your plan been reviewed since the last scan?
Send us the scans, marker report and the list of medicines you have had, and the tumour board can review what the next line should be. One helpline serves every CION centre.